TY - JOUR
T1 - Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway
AU - Funakoshi-Tago, Megumi
AU - Okamoto, Kazuhi
AU - Izumi, Rika
AU - Tago, Kenji
AU - Yanagisawa, Ken
AU - Narukawa, Yuji
AU - Kiuchi, Fumiyuki
AU - Kasahara, Tadashi
AU - Tamura, Hiroomi
N1 - Funding Information:
We thank Dr. Kazuo Umezawa (School of Medicine, Aichi Medical University) for the gift of DHMEQ. This work was supported in part by grants ( 25460073 ) from MEXT , Takeda Science Foundation , Uehara Memorial Foundation , and Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research . This work was also supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities .
Publisher Copyright:
© 2015 Elsevier B.V. All rights reserved.
PY - 2015/3
Y1 - 2015/3
N2 - Propolis has been used in folk medicine to improve health and prevent inflammatory diseases; however, the components that exhibit its anti-inflammatory activity remain unknown. We herein investigated the effects of flavonoids isolated from Nepalese propolis on the IL-33 signaling pathway to clarify the anti-inflammatory mechanism involved. Of the 8 types of flavonoids isolated from Nepalese propolis, 4 types of compounds, such as 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin, markedly inhibited the IL-33-induced mRNA expression of inflammatory genes including IL-6, TNFα and IL-13 in bone marrow-derived mast cells (BMMC). These four flavonoids also inhibited the IL-33-induced activation of nuclear factor κB (NF-κB), which was consistent with their inhibitory effects on cytokine expression. The effects of these flavonoids are attributed to inhibition of IL-33-induced activation of IKK, which leads to the degradation of IκBα and nuclear localization of NF-κB. On the other hand, other flavonoids isolated from Nepalese propolis, such as isoliquiritigenin, plathymenin, 7-hydroxyflavanone, and (+)-medicarpin, had no effect on the IL-33 signaling pathway or cytokine expression. Therefore, these results indicate that 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin are the substances responsible for the anti-inflammatory activity of Nepalese propolis.
AB - Propolis has been used in folk medicine to improve health and prevent inflammatory diseases; however, the components that exhibit its anti-inflammatory activity remain unknown. We herein investigated the effects of flavonoids isolated from Nepalese propolis on the IL-33 signaling pathway to clarify the anti-inflammatory mechanism involved. Of the 8 types of flavonoids isolated from Nepalese propolis, 4 types of compounds, such as 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin, markedly inhibited the IL-33-induced mRNA expression of inflammatory genes including IL-6, TNFα and IL-13 in bone marrow-derived mast cells (BMMC). These four flavonoids also inhibited the IL-33-induced activation of nuclear factor κB (NF-κB), which was consistent with their inhibitory effects on cytokine expression. The effects of these flavonoids are attributed to inhibition of IL-33-induced activation of IKK, which leads to the degradation of IκBα and nuclear localization of NF-κB. On the other hand, other flavonoids isolated from Nepalese propolis, such as isoliquiritigenin, plathymenin, 7-hydroxyflavanone, and (+)-medicarpin, had no effect on the IL-33 signaling pathway or cytokine expression. Therefore, these results indicate that 3′,4′-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin are the substances responsible for the anti-inflammatory activity of Nepalese propolis.
KW - Anti-inflammatory activity
KW - Flavonoid
KW - IKK
KW - IL-33
KW - NF-kB
KW - Propolis
UR - http://www.scopus.com/inward/record.url?scp=84922568635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922568635&partnerID=8YFLogxK
U2 - 10.1016/j.intimp.2015.01.012
DO - 10.1016/j.intimp.2015.01.012
M3 - Article
C2 - 25614224
AN - SCOPUS:84922568635
SN - 1567-5769
VL - 25
SP - 189
EP - 198
JO - International Immunopharmacology
JF - International Immunopharmacology
IS - 1
ER -